BridgeMD
New treatment option for Non-specific Chronic Neck Pain
Official title High-intensity Laser Therapy for Neck Pain
ClinicalTrials.gov ID: NCT05689788
What this study is testing
- What it's testing
- Chronic nonspecific neck pain is a common musculoskeletal disorder recognized for its high rates of disability and economic losses, ranking second in musculoskeletal conditions after low back pain. There are several effective physical therapy interventions to treat chronic nonspecific neck pain, such as laser therapy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participants must be at least 18 years old.
- Both sexes (men and women)
- Non-specific, chronic neck pain, defined as pain or discomfort in the cervical region between the superior nuchal line and the spinous process of T1...
You likely can't join if
- Neck or shoulder musculoskeletal injuries in the last 3 months (fractures, sprains, tendinopathies, dislocations, or muscle tears).
- Osteosynthesis materials close to the shoulders, neck, or surrounding areas.
- Wounds or skin changes in the shoulder and/or neck region (such as psoriasis, scars, or burns).
- Analgesic, anti-inflammatory, or muscle relaxant drugs for permanent use.
- Neurological alterations such as paresthesia, loss of sensation (partial or complete), decrease in strength, or color changes in the neck, arms...
- Diagnosed photosensitivity.
See the full eligibility criteria
- Participants must be at least 18 years old.
- Both sexes (men and women)
- Non-specific, chronic neck pain, defined as pain or discomfort in the cervical region between the superior nuchal line and the spinous process of T1 or the shoulder girdle, with the following criteria: neck pain in the...
- Neck or shoulder musculoskeletal injuries in the last 3 months (fractures, sprains, tendinopathies, dislocations, or muscle tears).
- Osteosynthesis materials close to the shoulders, neck, or surrounding areas.
- Wounds or skin changes in the shoulder and/or neck region (such as psoriasis, scars, or burns).
- Analgesic, anti-inflammatory, or muscle relaxant drugs for permanent use.
- Neurological alterations such as paresthesia, loss of sensation (partial or complete), decrease in strength, or color changes in the neck, arms, forearms, or hands.
- Diagnosed photosensitivity.
- Presence of solar urticaria or adverse reactions to sunlight.
- The presence of dermatomyositis, systemic lupus erythematosus, hepatic porphyria, cutaneous carcinoid syndrome, or pellagra.
- Cancer or tumors of some type have been diagnosed in the last 5 years.
- Epilepsy.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Las Condes, Chile
- Santiago, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Las Condes, Chile; Santiago, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.